The Systemic Inflammation Response Index (SIRI) for Stratifying Mortality Risk in Multidrug‐Resistant Lower Respiratory Tract Infections Acquired in Hospital Settings
Canadian Journal of Infectious Diseases and Medical Microbiology · 2026-01 · 2026 (1)
DOI: 10.1155/cjid/8850880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Infectious Diseases and Medical Microbiology, online erschienen am 10.09.2026. Verfasst von Xia Hui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Huan County People's Hospital, Qingyang, Gansu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Gansu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Timely risk assessment is important in the management of patients with multidrug‐resistant (MDR) hospital‐acquired lower respiratory tract infections (LRTI). The Systemic Inflammation Response Index (SIRI), an inflammatory biomarker derived from peripheral neutrophil, monocyte, and lymphocyte counts, has shown prognostic potential across several clinical settings. However, its prognostic value and clinically interpretable threshold in patients with MDR hospital‐acquired LRTI remain uncertain. This study aimed to evaluate the association between SIRI and in‐hospital mortality in this population.
Methods
This single‐center retrospective cohort study included 214 patients diagnosed with MDR hospital‐acquired LRTI, with all‐cause in‐hospital mortality as the primary outcome. Cox proportional hazards models were used to assess the prognostic value of SIRI. Restricted cubic splines were applied to examine potential nonlinear associations. A data‐driven cutoff was evaluated using Kaplan–Meier survival analysis and stratified receiver operating characteristic (ROC) analysis.
Results
When analyzed as a dichotomized variable using the data‐driven cutoff, high SIRI was associated with increased in‐hospital mortality (hazard ratio [HR] = 2.93, 95% confidence interval [CI]: 1.66–5.14, p < 0.001). Restricted cubic spline analysis suggested a nonlinear relationship, with risk increasing around a SIRI value of 3 and then approaching a high‐risk plateau. Kaplan–Meier analysis showed lower survival among patients with SIRI > 3 (log‐rank p < 0.001). However, stratified ROC analyses showed only modest discrimination when SIRI was treated as a continuous variable within the low‐risk (SIRI ≤ 3, area under the curve [AUC] = 0.556) and high‐risk (SIRI > 3, AUC = 0.567) subgroups.
Conclusion
SIRI may help identify a subgroup of patients with MDR hospital‐acquired LRTI who have a higher mortality risk, particularly when interpreted using a threshold of approximately 3.0. Given the modest ROC performance and retrospective single‐center design, this cutoff should be regarded as an exploratory risk‐stratification signal rather than a stand‐alone clinical decision tool. External prospective validation is required before clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Huan County People's Hospital, Qingyang, Gansu, China.
- Department of Respiratory and Critical Care Medicine, Ruijin Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, sjtu.edu.cn.
- Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China, fudan.edu.cn.
ORCID-Profile: Jiebai Zhou, Yun Feng, Haixing Zhu
Förderung
- Science and Technology Program of Gansu Province
- National Natural Science Foundation of China
Zitieren
APA
Hui, X., Ge, X., Liu, Y., Zhou, J., Feng, Y., & Zhu, H. (2026). The Systemic Inflammation Response Index (SIRI) for Stratifying Mortality Risk in Multidrug‐Resistant Lower Respiratory Tract Infections Acquired in Hospital Settings. Canadian Journal of Infectious Diseases and Medical Microbiology, 2026(1). https://doi.org/10.1155/cjid/8850880
Vancouver
Hui X, Ge X, Liu Y, Zhou J, Feng Y, Zhu H. The Systemic Inflammation Response Index (SIRI) for Stratifying Mortality Risk in Multidrug‐Resistant Lower Respiratory Tract Infections Acquired in Hospital Settings. Canadian Journal of Infectious Diseases and Medical Microbiology. 2026;2026(1). doi:10.1155/cjid/8850880
BibTeX
@article{Hui2026,
author = {Hui, Xia and Ge, Xiao and Liu, Yahui and Zhou, Jiebai and Feng, Yun and Zhu, Haixing},
title = {The Systemic Inflammation Response Index (SIRI) for Stratifying Mortality Risk in Multidrug‐Resistant Lower Respiratory Tract Infections Acquired in Hospital Settings},
journal = {Canadian Journal of Infectious Diseases and Medical Microbiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cjid/8850880}
}
EUVIMED